Home
Resources
Publications
Vigabatrin Lacks Proarrhythmic Potential: Results From a Thorough QT/QTc Study in Healthy Volunteers

Vigabatrin Lacks Proarrhythmic Potential: Results From a Thorough QT/QTc Study in Healthy Volunteers

Dwain Tolbert, Susan Reid, Stuart Harris, Ihor Bekersky

Clin Ther. 2017 Aug;39(8):1639-1648.

PMID: 28668627

Abstract:

Purpose:
A thorough QT study was performed to assess the proarrhythmic potential of vigabatrin, an antiepileptic drug approved in the United States for the treatment of infantile spasms and refractory complex partial seizures.
Methods:
In this Phase I, randomized, double-blind, placebo- and active-controlled (moxifloxacin), 4-sequence, crossover study conducted at a single center, healthy participants received 1 of 4 randomly assigned treatments: 3.0g vigabatrin solution (therapeutic dose) and 1 moxifloxacin placebo tablet; 6.0g vigabatrin solution (supratherapeutic dose) and 1 moxifloxacin placebo tablet; 400 mg moxifloxacin and vigabatrin placebo solution; moxifloxacin placebo tablet and vigabatrin placebo solution.
Findings:
Mean changes from baseline in placebo-corrected QTcF, QTcB, and QTcI with vigabatrin 3.0 g and 6.0 g indicated no signal for any QTc effect relative to baseline. All 1-sided upper 95% confidence intervals for the differences between each vigabatrin dose and placebo were <10 ms at all time points. QTcF was unaffected by increasing plasma vigabatrin concentrations; no arrhythmias were observed in any treatment group. Low rates of first-degree atrioventricular block, sinus tachycardia, and sinus bradycardia occurred in all treatment groups. Most adverse events were mild.
Implications:
The findings from this thorough QT study are consistent with existing clinical data and confirm a lack of proarrhythmic potential of vigabatrin.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP60643869	Vigabatrin solution		60643-86-9	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: